Rafferty Asset Management
AMLX icon

Rafferty Asset Management’s Amylyx Pharmaceuticals AMLX Stock Holding History

Rafferty Asset Management’s Portfolio AMLX Stock Details AMLX Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
2025
Q4 		$213K Buy
2024
Q2 		– Sell
2024
Q1 		$151K Buy
2023
Q4 		$270K Buy
2023
Q3 		$207K Buy
2023
Q1 		– Sell
2022
Q4 		$233K Buy